Medical devices, healthcare technology and the business of care
510(k) clearance · K262378

Dr.AlignNavi

InnoDtech, Inc. · Decision date Oct 7, 2026

MEDTECHLEDGER EXPLANATIONK262378

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Dr.AlignNavi, a 510(k) submitted by InnoDtech, Inc. of Gwangju, KR, under number K262378. The device falls under the classification name Orthodontic Software, regulation 872.5470, with primary product code PNN and subsequent product code LLZ. The application was received 07/13/2026 and decided 10/07/2026; the review panel and medical specialty are both Dental, and the submission is listed as Traditional, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE denotes clearance of this 510(k), not premarket approval of a new device system. The record does not describe the specific software functions, components, or any changed item, and no summary statement is present in the supplied data, so the basis for substantial equivalence and any clinical performance information remain unknown. CTNS Corp. is listed as correspondent, with Hyeon gu Lee as applicant contact and Eunsol Jung as correspondent contact.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Oct 7, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262378
Regulatory pathway
510(k) premarket notification
Product code
PNN
Decision code
SESE
Decision date
Oct 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthodontic Software.

Product code
PNN
FDA device class
2

FDA decision timeline

  1. K262378 received

    Application receipt date recorded by FDA.

  2. K262378 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PNN

Product / regulatory recordCompanyPathwayDecision dateSource
LuxDesignK260421
LuxCreo, Inc.510(k) clearanceOct 23, 2026FDA
Align Technology, Inc.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

InnoDtech, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Gwangju

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records